Doctors who prescribe medicinal cannabis “as a standalone practice” will need to undergo assessment from MDA National to confirm their cover as part of its new indemnity policy that starts on 1 July.  

The medical defence organisation has added standalone cannabis prescribing to its “unusual practice” list, alongside stem cell therapies and human growth hormone prescribing.